InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,580.31
(
0.13%
)
US TECH 100
19,925.60
(
0.16%
)
Dow Jones
39,443.55
(
0.25%
)
Brent Oil
84.62
(
-0.93%
)
Bitcoin
57,431.92
(
1.28%
)
Post# of 252528
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: genisi post# 97044

Thursday, 06/10/2010 11:12:30 AM

Thursday, June 10, 2010 11:12:30 AM

Post# of 252528
I believe the difference, in this specific instance, is just differing nomenclature.

These two shed some light on that issue (sort of):
http://en.wikipedia.org/wiki/HLA-A2
http://en.wikipedia.org/wiki/History_and_naming_of_human_leukocyte_antigens


This article doesn't even have the subtypes:
http://www.biomedcentral.com/1741-7015/4/5

I've seen ipi presentations at conferences use both notations and consistently describe each as present in ~50% of the population.

Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up